DEFINING SMALL AIRWAYS DISEASE AS A THERAPEUTIC TARGET IN POST-ACUTE SEQUELA OF COVID-19 (PASC)

$1,559,896FY2022Department of the ArmyDOD

The General Hospital Corporation

Investigators